Senju Pharmaceutical Beijing Co. Ltd., part of Senju Pharmaceutical Co., Ltd., is a company headquartered in Beijing, China, that manufactures and distributes pharmaceuticals.

Itoham Foods Inc. manufactures and sells processed meat products. It specializes in the business of livestock farming and processing and meat processing, packing and sales. The company was founded by Denzo Ito in April 1928 and is headquartered in Nishinomiya, Japan.

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

RegeneRx is a publicly traded, clinical-stage, biopharmaceutical company engaged in the design, research and development of novel peptides targeted at diseases with unmet medical needs. RegeneRx’s mission is to research and develop novel pharmaceuticals that protect and repair tissue and organ damage caused by disease, trauma or other pathology. RegeneRx acquired the rights to a novel peptide from the NIH in 1999. This intellectual property for Thymosin Beta 4 (Tβ4) allowed the company to direct its focus on tissue protection and repair in multiple disease indications. RegeneRx’s management team is focused on moving three distinct Tβ4-based drug candidates through the clinic: RGN-137, RGN-259 and RGN-352. RegeneRx also holds over 60 issued patents or filed patent applications worldwide in order to enable and protect multiple indications and applications for its product candidates. In addition to Tβ4, RegeneRx is developing Tβ4 peptide fragments for cosmeceutical applications, separate and distinct from the pharmaceutical peptide and formulations. RegeneRx intends to pursue strategic business relationships to develop these smaller peptides for the cosmeceutical market.

Aier Eye Hospital Group Co., Ltd. engages in the management and operation of ophthalmic chain medical institutions. It provides patients with ophthalmology medical services such as diagnosis, treatment and medical optometry of ophthalmic diseases. The company's medical treatments include myopia surgery, prevention & treatment of myopia, cataract, glaucoma, pediatric ophthalmology, fundus disease, eye shaping beauty, lacrimal pathology, cornea and ocular surface. Aier Eye Hospital Group was founded by Bang Chen and Li Li on January 24, 2003 and is headquartered in Changsha, China.

Beijing Boxin Kemei Biotechnology Co., Ltd., established on 2009-05-31, Business scope includes technical promotion services;Sales of machinery and equipment,Chemical Products(Free of Hazardous Chemicals),electronic product,Wujinjiaodian,Class I,Class II medical device;Sales of Class III medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Ningxia Tianren Wolfberry Biotechnology Co., Ltd., established on 2013-12-17, Business scope includes wolfberry planting,processing,Sales;Research and development of wolfberry products,Production,Sales;Pre-packaged food,Bulk Food Retail;food production,Sales;Cosmetic sales;seedlings,flower cultivation,Sales;gas appliance,household appliances,building materials,Decoration material sales;Landscaping;Business Information Consulting Service;Housing rental agency service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wakamoto Pharmaceutical is a pioneering company for self-medication with the launch of a nutrient-rich, gastrointestinal remedy. In recent years, the environment surrounding the pharmaceutical industry has been undergoing major changes. In particular, the baby boomer generation will reach age 75 or over and enter the senior citizen demographic in 2025, and Japan will face increasingly lower birth rates and a more aged society. Meanwhile, sustained systemic reform efforts are advancing for the National Health Insurance system, while fundamental reform of the drug pricing system progresses in order to reduce the medical expense burden on the nation. These shifts are occurring with unprecedented speed.

Shandong Weizhi Zhongke Pharmaceutical Co., Ltd., established on 2006-11-10, Business scope includes technology development in the field of biomedicine,technical consulting,Technical Services,technology transfer;solid preparations(tablet,Capsules,Granules)production and sales of;Engaged in import and export of goods and technology.(involving administrative licensing,The validity period is subject to the license;Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Shandong Weizhi Baike Pharmaceutical Co., Ltd., established on 2000-10-31, Business scope includes biological,Technical research and development in the field of medicine,technical consulting,Technical Services,technology transfer;Chemical API(Does not contain hazardous chemicals),Manufacture and sales of formulations;And engaged in the import and export of goods and technology import and export business(Does not contain publications and items prohibited by national policies).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Viwit Pharmaceuticals develops, manufactures, and distributes new products in the fields of finished dosage formulations, active pharmaceutical ingredients, and fine chemicals. they progressed from developing chiral borane compounds to producing drug intermediates, active pharmaceutical substances, and biopharmaceutical products.

Part of Motorola Solutions, Inc., MI, Inc. is a Japanese company located in Tokyo that operates an investment holding company.

Xiamen Shangjiayuan Biotechnology Co., Ltd., established on 2020-03-04, Business scope includes medical research and experimental development;Natural science research and experimental development;Biotechnology Extension Services;New material technology promotion service;Energy-saving technology promotion service;Other technical promotion services;Other unspecified technology promotion and application service industries;Other unlisted professional and technical service industries(Not subject to permit approval);Medical Information Consulting Service(Does not include drug information services,Disease diagnosis and treatment and other items subject to permit approval);Intellectual Property Services(Excluding patent agency affairs);Other unlisted business service industry(Items not subject to permit approval);Other unlisted professional consulting services(Items not subject to permit approval);software development;Information system integration service;Information Technology Consulting Services;Data Processing and Storage Services;IC Design;digital content service;Other unspecified information technology service industry(Items not subject to permit approval);Wholesale of Class I Medical Devices;Wholesale of Class II Medical Devices;Wholesale of other chemical products(Free of hazardous and monitored chemicals);computer,Wholesale of software and auxiliary equipment;Wholesale of other mechanical equipment and electronic products;Import and export of various commodities and technologies(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Other unspecified wholesale business(Does not include business items subject to permit approval);Retailing of Class I Medical Devices;Retailing of Class II Medical Devices;computer,Retailing of Software and Ancillary Equipment;Retailing of cosmetics and hygiene products;Other Electronics Retail;internet sales;Other unspecified retail trade(Items not subject to permit approval).